May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Early Lipoic Acid Intake Protects Retina in Diabetic Mice
Author Affiliations & Notes
  • F. J. Romero
    Physio/Pharma/Toxicology, Univ CEU-Cardenal Herrera, Moncada, Spain
    Fundación Oftalmológica del Mediterráneo, Valencia, Spain
  • S. Johnsen-Soriano
    Fundación Oftalmológica del Mediterráneo, Valencia, Spain
  • M. Sancho-Tello
    Fundación Oftalmológica del Mediterráneo, Valencia, Spain
  • M. Garcia-Pous
    Fundación Oftalmológica del Mediterráneo, Valencia, Spain
  • S. Garcia-Delpech
    Hospital General Universitario, Valencia, Spain
  • E. Arnal
    Physio/Pharma/Toxicology, Univ CEU-Cardenal Herrera, Moncada, Spain
  • M. Miranda
    Physio/Pharma/Toxicology, Univ CEU-Cardenal Herrera, Moncada, Spain
  • M. Diaz-Llopis
    Hospital General Universitario, Valencia, Spain
  • F. Bosch-Morell
    Physio/Pharma/Toxicology, Univ CEU-Cardenal Herrera, Moncada, Spain
    Fundación Oftalmológica del Mediterráneo, Valencia, Spain
  • Footnotes
    Commercial Relationships  F.J. Romero, None; S. Johnsen-Soriano, None; M. Sancho-Tello, None; M. Garcia-Pous, None; S. Garcia-Delpech, None; E. Arnal, None; M. Miranda, None; M. Diaz-Llopis, None; F. Bosch-Morell, None.
  • Footnotes
    Support  Grants from Fundación San Pablo.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5920. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. J. Romero, S. Johnsen-Soriano, M. Sancho-Tello, M. Garcia-Pous, S. Garcia-Delpech, E. Arnal, M. Miranda, M. Diaz-Llopis, F. Bosch-Morell; Early Lipoic Acid Intake Protects Retina in Diabetic Mice. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5920. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The aim of this study was to confirm biochemical and functional changes in retina after a short diabetic insult and to test the effect of lipoic acid treatment on those parameters.

Methods: : The investigation conformed with ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and Declaration of Helsinki. Diabetes was induced by a single subcutaneous injection of 200 mg alloxan/kg body weight (66 mg/ml) in 0.1 M citrate buffer, pH 4.5 and the control group received a subcutaneous injection of citrate buffer alone. Mice were considered diabetic with a blood glucose level higher than 16 mM, 4 days after alloxan treatment. Then, animals were divided into subgroups (control, control+lipoic acid, diabetic, diabetic+lipoic acid, diabetic+insulin, diabetic+insulin+lipoic acid) and maintained with their respective treatment for 3 weeks. At least 20 animals were used in each group. Lipoic acid (Sigma, St. Louis, MO, USA) was administered ip daily at a dose of 100 mg/kg body weight, and insulin at 500 mU/g body weight. Blood samples were taken daily from the tail vein to assay blood glucose levels. Glutathione (GSH) and Malondialdehyde (MDA) concentrations in addition to glutathione peroxidase activity (GPx activity) were measured in eye homogenates without lens as oxidative stress markers. The last day of the experiment electroretinograms (ERG) were recorded, and b-wave amplitudes were measured.

Results: : Early administration of lipoic acid prevented the statistically significant decrease of the antioxidant enxymes GSH and GPx activity and increase in MDA content observed in the retina of diabetic animals. Moreover, when functionality of the retina was tested in form of electroretinogram recordings, lipoic acid restored b-wave amplitude in diabetic animals to control values. In agreement with previous findings by other authors, no statistical significant increase in the number of TUNEL+ cells was found, though a slight increase was observed after this short diabetic insult.

Conclusions: : Lipoic acid has an protective effect by slowing the onset and progression of retinopathy, but must be administered as early as possible to the diabetic patients in order to prevent oxidative damage and its consequences such as apoptosis and possible vision loss.

Keywords: antioxidants • diabetic retinopathy • oxidation/oxidative or free radical damage 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×